PMC:7600245 / 9147-9328
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T63 | 18-24 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T77 | 4-8 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T78 | 89-100 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T70 | 0-181 | Sentence | denotes | The drug is being tested alone or in combination with merimepodib (NCT04410354; n = 40), tocilizumab (NCT04409262; REMDACTA; n = 450), or baricitinib (NCT04401579; ACTT2; n = 1034). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 164 | 54-65 | Chemical | denotes | merimepodib | MESH:C407002 |
| 165 | 89-100 | Chemical | denotes | tocilizumab | MESH:C502936 |
| 166 | 138-149 | Chemical | denotes | baricitinib | MESH:C000596027 |